Conditions: Post Ocular Surgical Inflammation and Pain
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 247
Healthy volunteers: no

Brief summary:
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (dexamethasone) depot when placed in the canaliculus of the eyelid for the treatment of post-surgical inflammation and pain in subjects who have undergone cataract extraction with intra-ocular lens implantation.

Detailed description:

Arms:
arm 1: Resorbable hydrogel drug delivery vehicle containing dexamethasone arm 2: Resorbable hydrogel drug delivery vehicle containing no drug

Interventions: intervention 1: Dexamethasone intervention 2: Punctum Plug
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: